Gentel Licenses OHSU Viral Antigens for its Simian Assay | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Gentel Biosciences today announced a licensing deal with Oregon Health & Science University covering viral antigens for use on its Colony Surveillance Assays.

The deal is for worldwide commercial use, and the addition of the antigens complements Gentel's strategy to grow its product line to support translational research disease models, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.